About Phil

Philip Mitchell has provided health regulatory counsel to a range of industry clients, including hospital systems, provider practice groups, management services organizations, clinical laboratories, managed care organizations and health insurers, pharmaceutical and biologic manufacturers, and specialty pharmacies, other proprietary and nonprofit healthcare enterprises, and investment firms.

View full bio

Experience

LB Pharmaceuticals Announces $285 Million Upsized IPO

LB Pharmaceuticals Announces $285 Million Upsized IPO

September 12, 2025

Cooley advised LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases including schizophrenia, on its $285 million upsized initial public offering (IPO).

Read more

Related contacts

Brandon W. Fenn
Partner, New York
Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Minkyu Park
Special Counsel, New York
Denny Xu
Associate, Boston
Danbi Kim
Associate, Boston
Ariane A. Andrade
Partner, Chicago
Nathaniel Hearn Jr.
Associate, Chicago
Karun Ahuja
Special Counsel, Chicago
Brandon Lefebvre
Quantitative Analyst, Boston
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
Eileen Marshall
Partner, Washington, DC
Phil Mitchell
Partner, New York
Gerard O'Shea
Partner, New York
David Peinsipp
Partner, San Francisco
Ryan Vann
Partner, Chicago
Francis Wheeler
Senior Counsel, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Jessica Koffel
Special Counsel, Brussels
Rebecca Ross
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Chelsea Braun
Associate, Boston
Cara Buchicchio
Associate, New York
David Dalton
Associate, Santa Monica
Vince Flynn
Associate, San Diego
Virat Gupta
Associate, Washington, DC
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Brenna McGuire
Associate, Washington, DC
Sarah Miller
Associate, New York
Jayne M. Munger
Associate, New York
Miles Patton
Associate, New York
Alla Kagan
Paralegal Specialist, San Diego
Cathy Rude
Paralegal Specialist, Boston
Jake Ironfield
Transactional Quantitative Analyst, New York
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Capital Markets
Life Sciences
Healthcare
Compensation and Benefits
Cyber/Data/Privacy
Tax
Life Sciences and Healthcare Regulatory
CFIUS
Labor and Employment
Antitrust and Competition

Tourmaline Bio Enters Into Agreement to be Acquired by Novartis

Tourmaline Bio Enters Into Agreement to be Acquired by Novartis

September 9, 2025

Read more

Related contacts

Bill Sorabella
Partner, New York
Brandon W. Fenn
Partner, New York
Natalie D. Vernon
Associate, Colorado
Sangitha Palaniappa
Associate, Palo Alto
Katherine Denby
Special Counsel, Washington, DC
Pengli Li
Associate, Boston
Nyron J. Persaud
Partner, New York
Megan Browdie
Partner, Washington, DC
Anne Luquette
Associate, San Francisco
Brittany Sanok
Associate, New York
Annie Froehlich
Partner, Washington, DC
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Eileen Marshall
Partner, Washington, DC
Carly Mitchell
Partner, Washington, DC
Phil Mitchell
Partner, New York
Ryan Montgomery
Partner, Boston
John Paul Oleksiuk
Partner, New York
Alan W. Tamarelli
Partner, New York
Dr. Michael Tuscan
Partner, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
J. Brian Stalter
Special Counsel, New York

Related Practices & Industries

Mergers and Acquisitions
Capital Markets
Biotechnology
Compensation and Benefits
Life Sciences Corporate Partnering and Licensing
Antitrust and Competition
Labor and Employment
Cyber/Data/Privacy
Tax
Trademark, Copyright and Advertising
Life Sciences and Healthcare Regulatory
Life Sciences
Commercial Litigation
Patent Counseling and Prosecution
Intellectual Property

MannKind to Acquire scPharmaceuticals for up to $360 Million

MannKind to Acquire scPharmaceuticals for up to $360 Million

August 25, 2025

Cooley advised MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, on its definitive merger agreement to acquire scPharmaceuticals for up to $360 million

Read more

Related contacts

Barbara Borden
Senior Counsel, San Diego
Rowook Park
Partner, San Diego
Julia Kim
Special Counsel, New York
Mischi a Marca
Partner, San Francisco
Adam J. Longenbach
Partner, New York
Matthew S. Scarano
Associate, San Diego
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Todd Gluth
Partner, San Diego
Eric Greig
Partner, Washington, DC
Asa Henin
Partner, San Diego
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Stella Sarma
Partner, Brussels
Charity Williams
Partner, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Emily Mason
Special Counsel, Santa Monica
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
David Dalton
Associate, Santa Monica
Sharon Davidov
Associate, New York
Jameson Davis
Associate, Boston
Athina Gaki
Associate, Brussels
Tony P. Guan
Associate, Santa Monica
Josh Himmelstern
Associate, San Diego
Michelle Hunt
Associate
Wyatt Kernell
Associate, Colorado
Bomin Kim
Associate, New York
Allison Kutner
Associate, New York
Jacob R. Lahana
Associate, Santa Monica
Eileen Leman
Associate, Los Angeles
Walter Musgrave
Associate, San Diego
Joseph Perry
Associate, Reston
Allie Pilmer
Associate, San Diego
Breanna Qin
Associate, Palo Alto
Vittoria Rainone
Associate, San Diego
Bartholomäus Regenhardt
Associate, Brussels
Brittany K. Wightman
Associate, San Diego
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC

Related Practices & Industries

Mergers and Acquisitions
Life Sciences Corporate Partnering and Licensing
Debt Finance
Labor and Employment
Life Sciences and Healthcare Regulatory
Life Sciences
Compensation and Benefits
Capital Markets
Tax
Cyber/Data/Privacy
Antitrust and Competition
Healthcare

Heartflow Announces $364.2 Million Upsized IPO

Heartflow Announces $364.2 Million Upsized IPO

August 11, 2025

Cooley advised the underwriters of Heartflow, a leader in artificial intelligence technology for coronary artery disease, in connection with Heartflow’s $364.2 million upsized initial public offering.

Read more

Related contacts

David Peinsipp
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
Denny Won
Partner, San Francisco
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Eric Greig
Partner, Washington, DC
Joanna Liebes Hubberts
Partner, San Diego
Dr. Madhuri Roy
Partner, Palo Alto
Rebecca Ross
Special Counsel, Washington, DC
Barbara Mirza
Partner, Santa Monica
Xander Lee
Partner, Santa Monica
Jane Adams
Partner, San Diego
Annie Froehlich
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Francis Wheeler
Senior Counsel, Colorado
Jessica Koffel
Special Counsel, Brussels
Dillon Martinson
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Max Gonzalez
Associate, Palo Alto
Peter A. Haddad
Associate, San Diego
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Ryan Lewis
Associate, Colorado
Tyler Saavedra-Buckley
Associate, San Francisco
Valerie Sapozhnikova
Associate, Los Angeles

Related Practices & Industries

Capital Markets
Artificial Intelligence
Life Sciences
Healthcare
Patent Counseling and Prosecution
Cyber/Data/Privacy
Life Sciences Corporate Partnering and Licensing
Life Sciences and Healthcare Regulatory
Compensation and Benefits
Tax
CFIUS
CooleyREG

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

August 6, 2025

Cooley advised MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, on an up to $500 million strategic financing agreement with funds managed by Blackstone.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Adam J. Longenbach
Partner, New York
Asa Henin
Partner, San Diego
Matthew S. Scarano
Associate, San Diego
Margaret Barreto
Associate, San Francisco
Charles A. Watkins II
Associate, Santa Monica
Kavi Huded
Associate, New York
Jeffrey J. Tolin
Partner, New York
David Dalton
Associate, Santa Monica
Natasha Leskovsek
Of Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
Charity Williams
Partner, San Diego
Karen Tsai
Special Counsel, Washington, DC
Dr. Jon Cousin
Partner, Washington, DC
Dr. Jason Valentine
Associate, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Allison Kutner
Associate, New York
Phil Mitchell
Partner, New York
Wyatt Kernell
Associate, Colorado
Kimberly Nguyen
Special Counsel, Reston
Peter Crain
Special Counsel, Reston
Kristine Forderer
Partner, San Francisco

Related Practices & Industries

Debt Finance
Life Sciences
Healthcare
Tax
Life Sciences and Healthcare Regulatory
Compensation and Benefits
Life Sciences Corporate Partnering and Licensing
CFIUS
Patent Counseling and Prosecution
Cyber/Data/Privacy
Technology Transactions
Real Estate
Environmental
View more

Admissions and credentials

New Jersey

New York

Pennsylvania

Rankings and accolades

Best Lawyers in America: Healthcare Law

Memberships and affiliations

American Bar Association (ABA)

American Health Lawyers Association